News Detail
New Delhi, 11 Dec 2024: The National Pharmaceutical Pricing Authority (NPPA) mandates for hospitals performing angioplasty to itemize billing costs for non-stent components alongside coronary stent details, Minister of State for Chemicals and Fertilizers, Anupriya Patel, recently......
View Details
Source : Medical Dialogues
national pharmaceutical pricing authority
nppa
coronary stents
angioplasty
billing transparency
non-stent components
price caps
cardiac catheters
balloon catheters
guide wire
dpco 2013
maximum retail price
mrp
healthcare institutions
itemized billing
hospital compliance
price inflation
accessibility
affordability
s v venkatesan
anupriya patel
parliamentary session
cardiac stent availability
price regulation
medical devices
non-scheduled devices
2023 study
lok sabha
Related News
- Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)
- 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)